Conformis Expands Scientific Advisory Board
Dr. Richard D. Scott Brings World-Renowned Partial Knee Expertise to Board
Burlington , Mass. – December 9, 2008 – Conformis, Inc., a medical device company that develops and commercializes patient-specific solutions for the treatment of osteoarthritis and joint damages, announced today the addition of Richard D. Scott, MD to their Scientific Advisory Board. The board comprises a group of world-class orthopedic surgeons and scientists who facilitate the company’s ongoing efforts to develop and deliver patient-specific solutions to patients.
Dr. Richard Scott is an internationally recognized expert in partial and total knee replacement. He currently holds a Professorship in Orthopedic Surgery at Harvard Medical School and is an orthopedist at Brigham and Women’s Hospital and the New England Baptist Hospital, both based in Boston, MA. Most recently, Dr. Scott served as the Chief of Implant Services at both the Brigham and Women’s and the Baptist Hospitals and as Chief of the Joint Arthroplasty Fellowship Program at Brigham and Women’s.
“We’re extremely pleased to have Dr. Scott join the Scientific Advisory Board,” said Philipp Lang, M.D., CEO of Conformis. “Dr. Scott’s unparalleled clinical experience combined with his track record of implant design innovation will serve as a tremendous asset to ourcurrent and future development efforts.”
Over his career, Cr. Scott has made significant contributions to the understanding of disease process and operative techniques in arthritic conditions. He has served as President of the Knee Society as well as on editorial boards for the Journal of Arthroplasty, the American Journal of Knee Surgery, Clinical Orthopedic and Related Research, and the Journal of Bone and Joint Surgery. He has also written extensively on arthritis and implant performance.
Dr. Scott will join three other leading orthopedic surgeons on the Scientific Advisory Board, including Thomas S. Thornhill, M.D., Chairman of the Department of Orthopedic Surgery at Brigham and Women’s Hospital, Tom Minas, M.D. M.S., Attending Orthopedic Surgeon at Brigham and Women’s Hospital, and Wolfgang Fitz. M.D., Associate Orthopedic Surgeon at Brigham and Women’s Hospital.
About Conformis, Inc.
Conformis, Inc. is a privately held company incorporated in 2004 that develops and commercializes medical devices for the treatment of osteoarthritis and joint damages. The Company’s novel and scaleable ‘image-to-implant’ process is comprised of two related technology platforms. iFit™ Technology enables the creation of conforming, patient-specific implants that are precisely sized and shaped to match the 3D topography of the patient’s anatomic bone surfaces. The iJig™ Instrumentation enables the creation of novel disposable instrumentation that radically simplifies and improves the surgical process.
Both platforms are supported by proprietary, intellectual property consisting of more than 120 issued, allowed and pending patents or patent applications that span imaging software, image processing, implant design, surgical techniques and instrumentation.
To date, Conformis has developed a comprehensive line of minimally traumatic, bone and cartilage-preserving knee implants and instrumentation designed to address all stages of osteoarthritis, the most common reason for knee replacement surgery. Each of these devices has been cleared by the US Food and Drug Administration for marketing in the U.S.
Conformis Announces U.S. Commercial Launch of Cordera™ Match Hip System
Cordera™ Match Hip System combines the proven Cordera™ hip stem with Conformis’ state-of-the-art, personalized pre-operative plans and patient-specific instruments. BILLERICA, Mass., December
Conformis Announces 510(k) Clearance for Cordera™ Hip System
Cordera™ Hip System with optional patient-specific instrumentation and personalized surgical plan joins the 3D Conformis Hip System as the latest